WEDNESDAY, Nov. 30, 2022 (HealthDay News) — An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report. The antiviral flu drug Tamiflu is in short supply for both adults and children, in both its brandContinue Reading

TUESDAY, Nov. 29, 2022 (HealthDay News) — Teenagers and young adults who use benzodiazepines to treat insomnia may be at heightened risk of overdose, a new study finds. Benzodiazepines include anxiety medications like Ativan, Klonopin, Valium and Xanax, as well as prescription sleep aids such as estazolam (ProSom), triazolam (Halcion)Continue Reading

WEDNESDAY, Nov. 23, 2022 (HealthDay News) — People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag. The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed itsContinue Reading

WEDNESDAY, Nov. 23, 2022 (HealthDay News) — It’s not too late to get the latest COVID-19 booster shot. Whether it’s the bivalent vaccine from drug maker Pfizer or from Moderna, the shots offer more protection against symptomatic infection, public health officials reiterated at a White House briefing on Tuesday. However,Continue Reading

MONDAY, Nov. 21, 2022 (HealthDay News) — Vaccines have become a hot topic in the past few years, but a new survey finds many parents aren’t discussing immunization with their child’s doctor. Though a child’s pediatrician has often been the go-to resource on vaccines, the University of Michigan Medicine pollContinue Reading

FRIDAY, Nov. 18, 2022 (HealthDay News) — Pfizer’s updated COVID booster shots are proving their mettle against emerging omicron variants, the company announced Friday. The latest version of the vaccine generated virus-fighting antibodies against four more omicron lineages, including the troubling BQ.1.1 variant. Notably, the immune response wasn’t as strongContinue Reading

FRIDAY, Nov. 18, 2022 (HealthDay News) — The Biden administration on Thursday offered assistance to communities and hospitals dealing with a surge in cases of pediatric respiratory illnesses, but it did not declare a national public health emergency. The Children’s Hospital Association and the American Academy of Pediatrics had askedContinue Reading